Type-2 diabetes patients at high risk for cardiovascular events: time to challenge the ‘metformin-always first’ paradigm

Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses

(2020) Joshua D Wallach et al.   BMJ-British Medical Journal

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update

(2020) Lorraine Lipscombe et al.   Canadian Journal of Diabetes

Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study

(2020) Louise A. Donnelly et al.   DIABETES CARE

Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

(2020) Christopher J L Murray et al.   LANCET

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2019) Francesco Cosentino et al.   EUROPEAN HEART JOURNAL

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

(2019) Salim Yusuf et al.   LANCET

Targets for blood glucose: What have the trials told us

(2019) Paul Valensi et al.   European Journal of Preventive Cardiology

2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2019) John B. Buse et al.   DIABETOLOGIA

Therapy of Type 2 Diabetes

(2019) Rüdiger Landgraf et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis

(2016) L.E. Chapman et al.   DIABETES & METABOLISM

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE